The GeneSight Psychotropic test analyzes how your genes may affect your outcomes with medications commonly prescribed to treat depression, anxiety, ADHD, and other mental health …

The GeneSight test analyzes clinically important genetic variations in your DNA. Results can inform your healthcare provider about how you may break down or respond to certain …

Nov 2, 2022 · The GeneSight test provides pharmacogenomic information for antidepressants, anxiolytics & hypnotics, antipsychotics, mood stabilizers, and stimulants & non-stimulants used …

What is the GeneSight Psychotropic test? The GeneSight Psychotropic test is a genetic test that shows your healthcare provider how your genes may affect medication outcomes.

Aug 15, 2018 · The GeneSight Psychotropic test uses a proprietary algorithm to analyze nine pharmacokinetic genes and five pharmacodynamic genes, weighing their combined influence …

What is the GeneSight ® test? The GeneSight Psychotropic test is designed to analyze clinically important genetic variations that may impact how your patients metabolize and respond to …

The GeneSight Psychotropic test is designed to analyze clinically important genetic variations that may impact how your patients metabolize and respond to certain mental health medications.

The GeneSight Report categorizes medications into intuitive, color-coded (green, yellow, red) categories based on an individual’s genetic results.

With the GeneSight test, your genetic makeup can provide clinicians with insight into how you may metabolize or respond to certain medications commonly prescribed to treat depression, …

Dec 1, 2021 · The GeneSight Psychotropic test has been evaluated in multiple published, peer-reviewed clinical studies. It is the only neuropsychiatric pharmacogenomic test backed by such …